Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ikapharmindo Putramas Tbk. (IKPM) vs Reksa Dana Indeks BNI-AM ETF MSCI Indonesia Selection (XBES) Price & Performance

Ikapharmindo Putramas Tbk.Trade
Reksa Dana Indeks BNI-AM ETF MSCI Indonesia SelectionTrade

Price performance (Past 24H)

Key statistics

Ikapharmindo Putramas Tbk. vs Reksa Dana Indeks BNI-AM ETF MSCI Indonesia Selection — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 313.35B, 1.41M 24h volume), while Reksa Dana Indeks BNI-AM ETF MSCI Indonesia Selection trades at Rp1,079 (market cap 215.8M). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 1452× Reksa Dana Indeks BNI-AM ETF MSCI Indonesia Selection's market cap. Which is the better fit depends on your goals.

IKPMXBES
Market Cap
313.35B215.8M
Volume
1.41M
Lot
14.1K
Turnover
271.25M
Average Price
192.33
Value
271.25M
Indicative Equilibrium Price
186
Indicative Equilibrium Volume
600

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IKPM
View details

About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.

Read more on IKPM

About Reksa Dana Indeks BNI-AM ETF MSCI Indonesia Selection

Read more on XBES